Skip to main content
MedWatcherBeta

Loading research and source information…

C-CAR168, an Autologous Anti-CD20/BCMA Chimeric Antigen Receptor T-Cell Therapy, in Participants With Progressive Multiple Sclerosis Refractory to Standard Therapy for Multiple sclerosis: evidence and status · MedWatcher